Authors
Loading...
Randomized trial reveals ZMIZ1 mutations drive T-ALL in children and adults, suggesting new therapeutic avenues.
Gomez‐Rivera et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: